Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 388

1.

Heritability of fetal hemoglobin, white cell count, and other clinical traits from a sickle cell disease family cohort.

Bao EL, Lareau CA, Brugnara C, Fulcher IR, Barau C, Moutereau S, Habibi A, Badaoui B, Berkenou J, Bartolucci P, Galactéros F, Platt OS, Mahaney M, Sankaran VG.

Am J Hematol. 2019 Jan 25. doi: 10.1002/ajh.25421. [Epub ahead of print]

PMID:
30680775
2.

Clinical and biological features in PIEZO1-hereditary xerocytosis and Gardos-channelopathy: A retrospective series of 126 patients.

Picard V, Guitton C, Thuret I, Rose C, Bendelac L, Ghazal K, Aguilar-Martinez P, Badens C, Barro C, Bénéteau C, Berger C, Cathébras P, Deconinck E, Delaunay J, Durand JM, Firah N, Galactéros F, Godeau B, Jaïs X, de Jaureguiberry JP, Le Stradic C, Lifermann F, Maffre R, Morin G, Perrin J, Proulle V, Ruivard M, Toutain F, Lahary A, Garçon L.

Haematologica. 2019 Jan 17. pii: haematol.2018.205328. doi: 10.3324/haematol.2018.205328. [Epub ahead of print]

3.

Moderate-intensity endurance-exercise training in patients with sickle-cell disease without severe chronic complications (EXDRE): an open-label randomised controlled trial.

Gellen B, Messonnier LA, Galactéros F, Audureau E, Merlet AN, Rupp T, Peyrot S, Martin C, Féasson L, Bartolucci P; EXDRE collaborative study group.

Lancet Haematol. 2018 Nov;5(11):e554-e562. doi: 10.1016/S2352-3026(18)30163-7.

PMID:
30389037
4.

Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding study.

Cappellini MD, Porter J, Origa R, Forni GL, Voskaridou E, Galactéros F, Taher AT, Arlet JB, Ribeil JA, Garbowski M, Graziadei G, Brouzes C, Semeraro M, Laadem A, Miteva D, Zou J, Sung V, Zinger T, Attie KM, Hermine O.

Haematologica. 2019 Mar;104(3):477-484. doi: 10.3324/haematol.2018.198887. Epub 2018 Oct 18.

5.

Severe, non specific symptoms in non-typhoidal Salmonella infections in adult patients with sickle cell disease: a retrospective multicentre study.

Guery R, Habibi A, Arlet JB, Lionnet F, de Lastours V, Decousser JW, Mainardi JL, Razazi K, Baranes L, Bartolucci P, Godeau B, Galacteros F, Michel M, Mahevas M.

Infect Dis (Lond). 2018 Nov - Dec;50(11-12):822-830. doi: 10.1080/23744235.2018.1500706. Epub 2018 Oct 14.

PMID:
30317897
6.

Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell disease.

Turpin M, Chantalat-Auger C, Parent F, Driss F, Lionnet F, Habibi A, Maître B, Huertas A, Jaïs X, Weatherald J, Montani D, Sitbon O, Simonneau G, Galactéros F, Humbert M, Bartolucci P, Savale L.

Eur Respir J. 2018 Oct 10;52(4). pii: 1800272. doi: 10.1183/13993003.00272-2018. Print 2018 Oct.

PMID:
30305330
7.

[Prevention of genetic diseases : the return of the family practitioner ?]

Derbez B, El Haffaf Z, Galactéros F, de Montgolfier S.

Rev Epidemiol Sante Publique. 2018 Sep 12. pii: S0398-7620(18)31317-8. doi: 10.1016/j.respe.2018.07.003. [Epub ahead of print] French.

PMID:
30219572
8.

A common functional PIEZO1 deletion allele associates with red blood cell density in sickle cell disease patients.

Ilboudo Y, Bartolucci P, Garrett ME, Ashley-Koch A, Telen M, Brugnara C, Galactéros F, Lettre G.

Am J Hematol. 2018 Nov;93(11):E362-E365. doi: 10.1002/ajh.25245. Epub 2018 Sep 9. No abstract available.

PMID:
30105803
9.

High immunogenicity of red blood cell antigens restricted to the population of African descent in a cohort of sickle cell disease patients.

Floch A, Gien D, Tournamille C, Chami B, Habibi A, Galactéros F, Bierling P, Djoudi R, Pondarré C, Peyrard T, Pirenne F.

Transfusion. 2018 Jun;58(6):1527-1535. doi: 10.1111/trf.14633. Epub 2018 Apr 29.

PMID:
29707783
10.

Transfusion-related adverse events are decreased in pregnant women with sickle cell disease by a change in policy from systematic transfusion to prophylactic oxygen therapy at home: A retrospective survey by the international sickle cell disease observatory.

Ribeil JA, Labopin M, Stanislas A, Deloison B, Lemercier D, Habibi A, Albinni S, Charlier C, Lortholary O, Lefrere F, De Montalembert M, Blanche S, Galactéros F, Tréluyer JM, Gluckman E, Ville Y, Joseph L, Delville M, Benachi A, Cavazzana M.

Am J Hematol. 2018 Jun;93(6):794-802. doi: 10.1002/ajh.25097. Epub 2018 Apr 17.

11.

Manipulating hemoglobin oxygenation using silica nanoparticles: a novel prospect for artificial oxygen carriers.

Devineau S, Kiger L, Galacteros F, Baudin-Creuza V, Marden M, Renault JP, Pin S.

Blood Adv. 2018 Jan 23;2(2):90-94. doi: 10.1182/bloodadvances.2017012153.

12.

Low fetal hemoglobin percentage is associated with silent brain lesions in adults with homozygous sickle cell disease.

Calvet D, Tuilier T, Mélé N, Turc G, Habibi A, Abdallah NA, Majhadi L, Hemery F, Edjlali M, Galacteros F, Bartolucci P.

Blood Adv. 2017 Dec 1;1(26):2503-2509. doi: 10.1182/bloodadvances.2017005504. eCollection 2017 Dec 12.

13.

Low-impact laparoscopic cholecystectomy is associated with decreased postoperative morbidity in patients with sickle cell disease.

de'Angelis N, Abdalla S, Carra MC, Lizzi V, Martínez-Pérez A, Habibi A, Bartolucci P, Galactéros F, Laurent A, Brunetti F.

Surg Endosc. 2018 May;32(5):2300-2311. doi: 10.1007/s00464-017-5925-y. Epub 2017 Nov 2.

PMID:
29098436
14.

α-Haemoglobin pool measurement: a useful biomarker for evaluation of β-thalassaemia intermedia? - response to Huang and Li.

Vasseur C, Galactéros F, Baudin-Creuza V.

Br J Haematol. 2018 Nov;183(4):671-673. doi: 10.1111/bjh.15007. Epub 2017 Oct 26. No abstract available.

PMID:
29076137
15.

Renin-angiotensin system blockade promotes a cardio-renal protection in albuminuric homozygous sickle cell patients.

Haymann JP, Hammoudi N, Stankovic Stojanovic K, Galacteros F, Habibi A, Avellino V, Bartolucci P, Benzerara Y, Arlet JB, Djebbar M, Letavernier E, Grateau G, Tabibzadeh N, Girshovich A, Chaignon M, Girot R, Levy P, Lionnet F.

Br J Haematol. 2017 Dec;179(5):820-828. doi: 10.1111/bjh.14969. Epub 2017 Oct 19.

PMID:
29048108
16.

Adverse effect of hydroxyurea on spermatogenesis in patients with sickle cell anemia after 6 months of treatment.

Berthaut I, Bachir D, Kotti S, Chalas C, Stankovic K, Eustache F, Ravel C, Habibi A, Brailly-Tabard S, Lévy-Dutel L, Bleibtreu A, Simon T, Galactéros F, Lionnet F, Mandelbaum J.

Blood. 2017 Nov 23;130(21):2354-2356. doi: 10.1182/blood-2017-03-771857. Epub 2017 Sep 28. No abstract available.

17.

Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.

Narbey D, Habibi A, Chadebech P, Mekontso-Dessap A, Khellaf M, Lelièvre JD, Godeau B, Michel M, Galactéros F, Djoudi R, Bartolucci P, Pirenne F.

Am J Hematol. 2017 Dec;92(12):1340-1348. doi: 10.1002/ajh.24908. Epub 2017 Oct 31.

18.

Incidence and predictors of portal and splenic vein thrombosis after pure laparoscopic splenectomy.

de'Angelis N, Abdalla S, Lizzi V, Esposito F, Genova P, Roy L, Galacteros F, Luciani A, Brunetti F.

Surgery. 2017 Dec;162(6):1219-1230. doi: 10.1016/j.surg.2017.07.016. Epub 2017 Sep 14.

PMID:
28919051
19.

Determination of hydroxyurea in human plasma by HPLC-UV using derivatization with xanthydrol.

Legrand T, Rakotoson MG, Galactéros F, Bartolucci P, Hulin A.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Oct 1;1064:85-91. doi: 10.1016/j.jchromb.2017.09.008. Epub 2017 Sep 7.

PMID:
28915422
20.

A clinical risk score for pulmonary artery thrombosis during acute chest syndrome in adult patients with sickle cell disease.

Winchenne A, Cecchini J, Deux JF, De Prost N, Razazi K, Carteaux G, Galacteros F, Habibi A, Bartolucci P, Melica G, Khellaf M, Michel M, Maitre B, Mekontso Dessap A.

Br J Haematol. 2017 Nov;179(4):627-634. doi: 10.1111/bjh.14914. Epub 2017 Sep 14.

PMID:
28905364
21.

Elevated soluble α-hemoglobin pool in sickle cell anemia.

Vasseur C, Domingues-Hamdi E, Pakdaman S, Barau C, Pissard S, Le Corvoisier P, Pirenne F, Galactéros F, Baudin-Creuza V.

Am J Hematol. 2017 Oct;92(10):E593-E595. doi: 10.1002/ajh.24835. Epub 2017 Jul 24. No abstract available.

22.

Red blood cells free α-haemoglobin pool: a biomarker to monitor the β-thalassemia intermedia variability. The ALPHAPOOL study.

Vasseur C, Domingues-Hamdi E, Ledudal K, Le Corvoisier P, Barau C, Ghaleh B, Rialland A, Pissard S, Galactéros F, Baudin-Creuza V.

Br J Haematol. 2017 Oct;179(1):142-153. doi: 10.1111/bjh.14800. Epub 2017 Jun 23.

PMID:
28643346
23.

Genome-wide association study of erythrocyte density in sickle cell disease patients.

Ilboudo Y, Bartolucci P, Rivera A, Sedzro JC, Beaudoin M, Trudel M, Alper SL, Brugnara C, Galactéros F, Lettre G.

Blood Cells Mol Dis. 2017 Jun;65:60-65. doi: 10.1016/j.bcmd.2017.05.005. Epub 2017 May 13.

PMID:
28552477
24.

Telomere attrition in sickle cell anemia.

Mekontso Dessap A, Cecchini J, Chaar V, Marcos E, Habibi A, Bartolucci P, Ghaleh B, Galacteros F, Adnot S.

Am J Hematol. 2017 Jun;92(6):E112-E114. doi: 10.1002/ajh.24721. Epub 2017 Apr 18. No abstract available.

25.

Variant-aware saturating mutagenesis using multiple Cas9 nucleases identifies regulatory elements at trait-associated loci.

Canver MC, Lessard S, Pinello L, Wu Y, Ilboudo Y, Stern EN, Needleman AJ, Galactéros F, Brugnara C, Kutlar A, McKenzie C, Reid M, Chen DD, Das PP, A Cole M, Zeng J, Kurita R, Nakamura Y, Yuan GC, Lettre G, Bauer DE, Orkin SH.

Nat Genet. 2017 Apr;49(4):625-634. doi: 10.1038/ng.3793. Epub 2017 Feb 20.

26.

Factors predictive of leg-ulcer healing in sickle cell disease: a multicentre, prospective cohort study.

Senet P, Blas-Chatelain C, Levy P, Manea EM, Peschanski M, Mirault T, Stankovic-Stojanovic K, Debure C, Debbache K, Girot R, Bureau JM, Bachmeyer C, Baldeschi C, Galacteros F, Lionnet F, Gellen-Dautremer J.

Br J Dermatol. 2017 Jul;177(1):206-211. doi: 10.1111/bjd.15241. Epub 2017 Apr 26.

PMID:
27992062
27.

Arterio-venous fistula for automated red blood cells exchange in patients with sickle cell disease: Complications and outcomes.

Delville M, Manceau S, Ait Abdallah N, Stolba J, Awad S, Damy T, Gellen B, Sabbah L, Debbache K, Audard V, Beaumont JL, Arnaud C, Chantalat-Auger C, Driss F, Lefrère F, Cavazzana M, Franco G, Galacteros F, Ribeil JA, Gellen-Dautremer J.

Am J Hematol. 2017 Feb;92(2):136-140. doi: 10.1002/ajh.24600. Epub 2016 Dec 7.

28.

Magnetic Resonance Imaging Assessment of Kidney Oxygenation and Perfusion During Sickle Cell Vaso-occlusive Crises.

Deux JF, Audard V, Brugières P, Habibi A, Manea EM, Guillaud-Danis C, Godeau B, Galactéros F, Stehlé T, Lang P, Grimbert P, Audureau E, Rahmouni A, Bartolucci P.

Am J Kidney Dis. 2017 Jan;69(1):51-59. doi: 10.1053/j.ajkd.2016.07.027. Epub 2016 Sep 20.

PMID:
27663041
29.

Reversible kidney iron accumulation in a patient with sickle cell disease treated with hydroxyurea.

Stehlé T, Bartolucci P, Bouanane M, Galacteros F, Dudreuilh C, Grimbert P, Deux JF, Audard V.

Am J Hematol. 2016 Dec;91(12):1283-1284. doi: 10.1002/ajh.24544. Epub 2016 Oct 14. No abstract available.

30.

A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell disease.

Mekontso Dessap A, Pirenne F, Razazi K, Moutereau S, Abid S, Brun-Buisson C, Maitre B, Michel M, Galacteros F, Bartolucci P, Habibi A.

Am J Hematol. 2016 Dec;91(12):1181-1184. doi: 10.1002/ajh.24537. Epub 2016 Sep 7.

31.

Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients.

Bartolucci P, Habibi A, Khellaf M, Roudot-Thoraval F, Melica G, Lascaux AS, Moutereau S, Loric S, Wagner-Ballon O, Berkenou J, Santin A, Michel M, Renaud B, Lévy Y, Galactéros F, Godeau B.

EBioMedicine. 2016 Aug;10:305-11. doi: 10.1016/j.ebiom.2016.06.038. Epub 2016 Jun 29.

32.

Talar Osteonecrosis Related to Adult Sickle Cell Disease: Natural Evolution from Early to Late Stages.

Hernigou P, Flouzat-Lachaniette CH, Daltro G, Galacteros F.

J Bone Joint Surg Am. 2016 Jul 6;98(13):1113-21. doi: 10.2106/JBJS.15.01074.

PMID:
27385685
33.

Dense red blood cell and oxygen desaturation in sickle-cell disease.

Di Liberto G, Kiger L, Marden MC, Boyer L, Poitrine FC, Conti M, Rakotoson MG, Habibi A, Khorgami S, Vingert B, Maitre B, Galacteros F, Pirenne F, Bartolucci P.

Am J Hematol. 2016 Oct;91(10):1008-13. doi: 10.1002/ajh.24467. Epub 2016 Aug 4.

34.

Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes.

Habibi A, Mekontso-Dessap A, Guillaud C, Michel M, Razazi K, Khellaf M, Chami B, Bachir D, Rieux C, Melica G, Godeau B, Galacteros F, Bartolucci P, Pirenne F.

Am J Hematol. 2016 Oct;91(10):989-94. doi: 10.1002/ajh.24460. Epub 2016 Jul 14.

35.

Pulmonary Vascular Dysfunction and Cor Pulmonale During Acute Respiratory Distress Syndrome in Sicklers.

Cecchini J, Boissier F, Gibelin A, de Prost N, Razazi K, Carteaux G, Galacteros F, Maitre B, Brun-Buisson C, Mekontso Dessap A.

Shock. 2016 Oct;46(4):358-64. doi: 10.1097/SHK.0000000000000640.

PMID:
27206275
36.

Evidence of benefits from using fresh and cryopreserved blood to transfuse patients with acute sickle cell disease.

Chadebech P, de Ménorval MA, Bodivit G, Mekontso-Dessap A, Pakdaman S, Jouard A, Galactéros F, Bierling P, Habibi A, Pirenne F.

Transfusion. 2016 Jul;56(7):1730-8. doi: 10.1111/trf.13636. Epub 2016 May 17.

PMID:
27184475
37.

Pulmonary and cerebral microvasculopathy in a patient with sickle cell disease: A role for dense red blood cells?

Ségot A, Deux JF, Thuillier T, Maitre B, Galactéros F, Bartolucci P.

Am J Hematol. 2016 Sep;91(9):963-4. doi: 10.1002/ajh.24413. Epub 2016 Jul 14. No abstract available.

38.

Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients.

Ibanez C, Habibi A, Mekontso-Dessap A, Chadebech P, Chami B, Bierling P, Galactéros F, Rieux C, Nataf J, Bartolucci P, Peyrard T, Pirenne F.

Transfusion. 2016 Jul;56(7):1828-33. doi: 10.1111/trf.13611. Epub 2016 May 3.

PMID:
27145018
39.

Morbidity and mortality of sickle cell disease patients starting intermittent haemodialysis: a comparative cohort study with non- Sickle dialysis patients.

Nielsen L, Canouï-Poitrine F, Jais JP, Dahmane D, Bartolucci P, Bentaarit B, Gellen-Dautremer J, Remy P, Kofman T, Matignon M, Suberbielle C, Jacquelinet C, Wagner-Ballon O, Sahali D, Lang P, Damy T, Galactéros F, Grimbert P, Habibi A, Audard V.

Br J Haematol. 2016 Jul;174(1):148-52. doi: 10.1111/bjh.14040. Epub 2016 Mar 17.

PMID:
26992059
40.

[Kidney and hemoglobinopathy].

Rémy P, Audard V, Galactéros F.

Nephrol Ther. 2016 Apr;12(2):117-29. doi: 10.1016/j.nephro.2016.01.001. Review. French.

PMID:
26947986
41.

Bedside Lung Ultrasound During Acute Chest Syndrome in Sickle Cell Disease.

Razazi K, Deux JF, de Prost N, Boissier F, Cuquemelle E, Galactéros F, Rahmouni A, Maître B, Brun-Buisson C, Mekontso Dessap A.

Medicine (Baltimore). 2016 Feb;95(7):e2553. doi: 10.1097/MD.0000000000002553.

42.

Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients.

Dumas G, Habibi A, Onimus T, Merle JC, Razazi K, Mekontso Dessap A, Galactéros F, Michel M, Frémeaux Bacchi V, Noizat Pirenne F, Bartolucci P.

Blood. 2016 Feb 25;127(8):1062-4. doi: 10.1182/blood-2015-09-669770. Epub 2016 Jan 12. No abstract available.

43.

Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease.

Bartolucci P, Habibi A, Stehlé T, Di Liberto G, Rakotoson MG, Gellen-Dautremer J, Loric S, Moutereau S, Sahali D, Wagner-Ballon O, Remy P, Lang P, Grimbert P, Audureau E, Godeau B, Galacteros F, Audard V.

J Am Soc Nephrol. 2016 Jun;27(6):1847-53. doi: 10.1681/ASN.2014111126. Epub 2015 Nov 19.

44.

Haematological determinants of cardiac involvement in adults with sickle cell disease.

Damy T, Bodez D, Habibi A, Guellich A, Rappeneau S, Inamo J, Guendouz S, Gellen-Dautremer J, Pissard S, Loric S, Wagner-Ballon O, Godeau B, Adnot S, Dubois-Randé JL, Hittinger L, Galactéros F, Bartolucci P.

Eur Heart J. 2016 Apr 7;37(14):1158-1167. doi: 10.1093/eurheartj/ehv555. Epub 2015 Oct 29.

PMID:
26516176
45.

Autologous bone marrow stromal cells are promising candidates for cell therapy approaches to treat bone degeneration in sickle cell disease.

Lebouvier A, Poignard A, Coquelin-Salsac L, Léotot J, Homma Y, Jullien N, Bierling P, Galactéros F, Hernigou P, Chevallier N, Rouard H.

Stem Cell Res. 2015 Nov;15(3):584-594. doi: 10.1016/j.scr.2015.09.016. Epub 2015 Oct 8.

46.

Maternal mortality among women with sickle-cell disease in France, 1996-2009.

Lesage N, Deneux Tharaux C, Saucedo M, Habibi A, Galacteros F, Girot R, Bouvier Colle MH, Kayem G.

Eur J Obstet Gynecol Reprod Biol. 2015 Nov;194:183-8. doi: 10.1016/j.ejogrb.2015.09.016. Epub 2015 Sep 25.

PMID:
26431903
47.

Inhaled nitric oxide for acute chest syndrome in adult sickle cell patients: a randomized controlled study.

Maitre B, Djibre M, Katsahian S, Habibi A, Stankovic Stojanovic K, Khellaf M, Bourgeon I, Lionnet F, Charles-Nelson A, Brochard L, Lemaire F, Galacteros F, Brun-Buisson C, Fartoukh M, Mekontso Dessap A.

Intensive Care Med. 2015 Dec;41(12):2121-9. doi: 10.1007/s00134-015-4060-2. Epub 2015 Oct 2.

PMID:
26431718
48.

[Symptomatic extramedullary haematopoiesis in β-thalassemia: A retrospective single centre study].

Maazoun F, Gellen Dautremer J, Boutekadjirt A, Pissard S, Habibi A, Bachir D, Rahmouni A, Bartolucci P, Debbache K, Lagrange JL, Michel M, Galacteros F.

Rev Med Interne. 2016 Jan;37(1):5-12. doi: 10.1016/j.revmed.2015.07.005. Epub 2015 Sep 26. French.

PMID:
26410419
49.

2015 Clinical trials update in sickle cell anemia.

Archer N, Galacteros F, Brugnara C.

Am J Hematol. 2015 Oct;90(10):934-50. doi: 10.1002/ajh.24116. Review.

50.

Transfusion service management of sickle-cell disease patients.

Yazer MH, Lozano M, Crighton G, Greenway A, Comande M, Savoia H, Wood E, Gilli S, Castilho L, Saad ST, Galactéros F, Noizat-Pirenne F, Pazgal I, Stark P, Orlin Y, Perseghin P, Masera N, Cela E, Anguita J, Wikman A, Delaney M.

Vox Sang. 2016 Apr;110(3):288-94. doi: 10.1111/vox.12296. Epub 2015 Jul 14. No abstract available.

PMID:
26177989

Supplemental Content

Loading ...
Support Center